Dr. Reddy’s Is First Indian Pharma Firm Accepted Under China’s New Drug-Buying Plan
Capsules are laid out for inspection on the production line of a drug factory. (Photographer: Tomohiro Ohsumi/Bloomberg)

Dr. Reddy’s Is First Indian Pharma Firm Accepted Under China’s New Drug-Buying Plan

Dr. Reddy’s Laboratories Ltd. is the first Indian drugmaker to win an approval to supply a key drug to treat schizophrenia and bipolar disorder in China after the world’s second-largest pharma mark...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.